Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

AstraZeneca

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Employees: 89.9K

Market Cap: $270.3B

Website: http://www.astrazeneca.co.uk

Introduction: AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Clinical Trials

Longitudinal Study of Patients With Opioid-Induced Constipation

Completed

Conditions: Patients With Opioid Induced Constipation

First Posted Date: 2013-08-27

Last Posted Date: 2015-07-08

Lead Sponsor: AstraZeneca

Target Recruit Count: 520

Registration Number: NCT01928953

Locations: 🇺🇸
Physician Care Clinical Research, LLC, Sarasota, Florida, United States
🇨🇦
Taunton Health Centre, Oshawa, Ontario, Canada
🇺🇸
Chicago Anesthesia Pain Specialists, Chicago, Illinois, United States

and more 27 locations

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Phase 3

Completed

Conditions: Asthma

Interventions: Biological: Benralizumab
Biological: Placebo

First Posted Date: 2013-08-27

Last Posted Date: 2017-05-03

Lead Sponsor: AstraZeneca

Target Recruit Count: 2681

Registration Number: NCT01928771

Locations: 🇻🇳
Research Site, Ho Chi Minh, Vietnam

Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability

Phase 2

Completed

Conditions: Diabetic Neuropathy, Painful; Diabetic Neuropathies

Interventions: Drug: Placebo
Drug: pregabalin capsules
Drug: AZD5213 + pregabalin

First Posted Date: 2013-08-23

Last Posted Date: 2016-10-03

Lead Sponsor: AstraZeneca

Target Recruit Count: 150

Registration Number: NCT01928381

Locations: 🇺🇸
Research Site, Philadelphia, Pennsylvania, United States

AZD6423 SAD/MAD Study in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers.

Interventions: Drug: AZD6423
Drug: Placebo

First Posted Date: 2013-08-20

Last Posted Date: 2014-04-04

Lead Sponsor: AstraZeneca

Target Recruit Count: 175

Registration Number: NCT01926366

Locations: 🇺🇸
Research Site, Glendale, California, United States

Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.

Phase 3

Completed

Conditions: Gastric Cancer

Interventions: Drug: Olaparib
Drug: Placebo
Drug: Paclitaxel

First Posted Date: 2013-08-16

Last Posted Date: 2024-03-22

Lead Sponsor: AstraZeneca

Target Recruit Count: 525

Registration Number: NCT01924533

Locations: 🇨🇳
Research Site, Taoyuan, Taiwan

Prilosec Bioequivalence Study in Healthy Volunteers

Phase 1

Completed

Conditions: Bioequivalence, AUC, Cmax, Pharmacokinetics

Interventions: Drug: Omeprazole

First Posted Date: 2013-08-14

Last Posted Date: 2013-11-25

Lead Sponsor: AstraZeneca

Target Recruit Count: 54

Registration Number: NCT01921920

Locations: 🇺🇸
Research Site, Overland Park, Kansas, United States

To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours

Phase 1

Completed

Conditions: Solid Tumours

Interventions: Drug: Olaparib tablets
Procedure: Pharmacokinetic sampling
Other: Dietary High Fat
Other: Dietary Fasted

First Posted Date: 2013-08-13

Last Posted Date: 2022-11-22

Lead Sponsor: AstraZeneca

Target Recruit Count: 60

Registration Number: NCT01921140

Locations: 🇬🇧
Research Site, Surrey, United Kingdom

Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients

Completed

Conditions: COPD

First Posted Date: 2013-08-13

Last Posted Date: 2016-02-03

Lead Sponsor: AstraZeneca

Target Recruit Count: 3000

Registration Number: NCT01921127

Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients

Completed

Conditions: COPD Exacerbation

First Posted Date: 2013-08-07

Last Posted Date: 2016-02-03

Lead Sponsor: AstraZeneca

Target Recruit Count: 2396

Registration Number: NCT01917643

Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Phase 3

Completed

Conditions: Asthma

Interventions: Biological: Placebo
Biological: Benralizumab

First Posted Date: 2013-08-02

Last Posted Date: 2017-01-25

Lead Sponsor: AstraZeneca

Target Recruit Count: 2508

Registration Number: NCT01914757

Locations: 🇺🇦
Research Site, Zaporozhye, Ukraine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy